•  
  •  
Who Are We...... we  are  health minded- thinking big – innovative – aggressive 

Dr. Brazos Minshew, CSO

Dr. Brazos G. Minshew, CSO/Ip Development
  • Dr. Minshew is a serial CSO in the Nutraceutical and BioCeutical space, that has also served as a clinician in Functional Medicine for more than twenty years.

  • He has developed products since 1983 which have gone on to yield over $1B(U.S.) in sales, and has also written four books with over a million copies sold.

  • Dr. Minshew had taught at Colleges and Universities around the World, hosted 35 television shows, 100 radio shows and podcasts.


The right team in the right place...

L9 BIOSCIENCE: WHO ARE WE?

•L9 BioScience is a technology that increases the bioavailability of all Active Pharmaceutical Ingredients (API’s)
•9-fold to 18-fold increase in API bioavailability
•The L9 process improves clinical outcomes, reduces toxicity and reduces cost
•Up to 50% API retention without bioaccumulation
•The L9 process is patented, with 16 more discreet claims in the patent landscape


DISCLAIMER

The material contained in this presentation is provided solely for your general knowledge and is not intended to be a comprehensive review of all matters and developments concerning L9 BioScience Inc. L9 BioScience Inc. makes no representation or warranty regarding, and assumes no responsibility for, the use, validity, accuracy, completeness, reliability, or currency of any claims, statements, or information in this summary.

The information contained in this presentation does not constitute and should not be interpreted as an offer or the solicitation of an offer for the purchase of any securities of L9 BioScience Inc.. This information is not intended in any way to qualify, modify, or supplement any information disclosed under the corporate and securities laws of any jurisdiction applicable to L9 BioScience Inc.. No securities commission or similar authority in Canada or any other country or jurisdiction has in any way passed on any of the information contained in this summary.

FORWARD LOOKING INFORMATION

Those reading or otherwise using the information contained within the projection models must be caustioned that it contains and comprises forward-looking financial information and statements that are generally anticipated, expected or projected by L9 BioScience Inc. and involved known and unknown risks, uncertainties and other factors which may cause the actual performance of the company to be materially different from the future results or performance expressed or implied.

Potential risks and uncertainties include, without limitation, the uncertainties inherent in the development of L9 BioScience Inc. technology, its need for significant additional funding and rapid developments in technology, including developments by its competitors. These projections and any forward-looking information are not guarantees of future performance, since they involve risks, uncertainties and assumptions, which may cause results to differ materially from those anticipated in these projections and any forward-looking statements made.